SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-000419
Filing Date
2020-01-09
Accepted
2020-01-09 16:57:03
Documents
20
Period of Report
2019-11-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 87500
2 ex4-1.htm EX-4.1 78532
3 ex4-2.htm EX-4.2 50770
4 ex4-3.htm EX-4.3 84201
5 ex4-4.htm EX-4.4 87238
6 ex4-5.htm EX-4.5 64356
7 ex4-6.htm EX-4.6 96906
8 ex4-7.htm EX-4.7 85054
9 ex99-1.htm EX-99.1 17400
10 ex99-2.htm EX-99.2 16819
11 ex99-3.htm EX-99.3 16070
12 ex99-4.htm EX-99.4 19498
13 ex99-5.htm EX-99.5 15345
14 ex4-5_001.jpg GRAPHIC 4180
15 ex4-5_002.jpg GRAPHIC 912907
16 ex99-1_001.jpg GRAPHIC 3524
17 ex99-1_002.jpg GRAPHIC 18244
18 ex99-2_001.jpg GRAPHIC 1901
19 ex99-2_002.jpg GRAPHIC 62399
20 ex99-3_01.jpg GRAPHIC 1900
  Complete submission text file 0001493152-20-000419.txt   2106475
Mailing Address 555 MADISON AVENUE 5TH FLOOR SUITE 506 NEW YORK NY 10022
Business Address 555 MADISON AVENUE 5TH FLOOR SUITE 506 NEW YORK NY 10022 917-796-9926
TAURIGA SCIENCES, INC. (Filer) CIK: 0001142790 (see all company filings)

IRS No.: 651102237 | State of Incorp.: FL | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-53723 | Film No.: 20518677
SIC: 2833 Medicinal Chemicals & Botanical Products